← Back to Clinical Trials
Recruiting NCT06776562

NCT06776562 Effect of Corrective Exercises on Dynamic Knee Valgus

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06776562
Status Recruiting
Phase
Sponsor Medipol University
Condition Dynamic Knee Valgus
Study Type INTERVENTIONAL
Enrollment 33 participants
Start Date 2024-10-11
Primary Completion 2025-03-22

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age 25 Years
Study Type INTERVENTIONAL
Interventions
ExerciseControl

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 33 participants in total. It began in 2024-10-11 with a primary completion date of 2025-03-22.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Dynamic knee valgus (DKV) is a movement pattern of the lower limb potentially consisting of a combination of adduction and internal rotation of the femur, knee abduction, tibial anterior translation, tibial external rotation and ankle eversion. Average "normal" performance during a fall jump landing mission knee valgus angle should be in the range of 7-13 degrees in women and 3-8 degrees in men. This faulty movement pattern is a common dysfunction observed in the lower limb during dynamic activities. On the other hand, this is reported to be the underlying mechanism of knee injuries. Changes in knee valgus increase abnormal stresses on the tibiofemoral joint and increase the risk of injuries such as anterior cruciate ligament injuries, patellofemoral pain, iliotibial band syndrome, chronic ankle instability, acute lateral ankle sprains. The main cause of DKV is deficits in neuromuscular control and therefore injury prevention and rehabilitation strategies focus on improving neuromuscular control to avoid these injury mechanisms. There are conflicting results in the literature regarding which of the exercise approaches is superior for DKV, and there is a lack of studies evaluating 2D movement analysis, muscle mechanics and performance of corrective exercise training. Identifying individuals with abnormal movement patterns and those at risk is important to prevent future injuries. The aim of the study was to investigate the effect of corrective exercises on lower extremity biomechanics and performance in individuals with asymptomatic dynamic knee valgus.

Eligibility Criteria

Inclusion Criteria: * Between 18 and 25 years of age * Have asymptomatic dynamic knee valgus * Being woman Exclusion Criteria: * BMI≥ 30 kg/cm2 * Lower extremity musculoskeletal pain * Lower extremity injury in the past 1 year * History of lower limb surgery * Neurological condition that may affect balance and coordination during the test * More than half an hour of intense exercise per week * Those who exercise vigorously for more than half an hour per week

Frequently Asked Questions

Who can join the NCT06776562 clinical trial?

This trial is open to female participants only, aged 18 Years or older, up to 25 Years, studying Dynamic Knee Valgus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06776562 currently recruiting?

Yes, NCT06776562 is actively recruiting participants. Visit ClinicalTrials.gov or contact Medipol University to inquire about joining.

Where is the NCT06776562 trial being conducted?

This trial is being conducted at Istanbul, Turkey (Türkiye).

Who is sponsoring the NCT06776562 clinical trial?

NCT06776562 is sponsored by Medipol University. The trial plans to enroll 33 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology